Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

1.4K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.4K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

866
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
866
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

1.5K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.5K
Chemical Synapses01:26

Chemical Synapses

4.2K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

No gold standard has been established for vasoreactivity testing in patients with coronary microvascular spasm in the real world: A future task?

Internal medicine (Tokyo, Japan)·2026
Same author

Differences in Coronary Microvascular Spasms Induced by Acetylcholine and Ergonovine.

Internal medicine (Tokyo, Japan)·2025
Same author

The Need for Separate Testing with Acetylcholine for the Assessment of Endothelial Dysfunction and Coronary Artery Spasm.

European cardiology·2024
Same author

Safety and Usefulness of Intracoronary Acetylcholine 200 μg Into the Left Coronary Artery as Vasoreactivity Testing: Comparisons With Intracoronary Acetylcholine Maximum 100 μg.

Clinical cardiology·2024
Same author

A Review of the Role of Tests of Coronary Reactivity in Clinical Practice.

European cardiology·2024
Same author

Lack of Class I Vasoreactivity Testing for Diagnosing Patients With Coronary Artery Spasm.

Clinical cardiology·2024

Related Experiment Video

Updated: Jan 5, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

16.6K

Transitional changes of acetylcholine spasm provocation test procedures.

Shozo Sueda1, Hiroaki Kohno2

  • 1The Department of Cardiology, Ehime Prefectual Niihama Hospital, Hongou 3 Choume 1-1, Niihama City, Ehime Prefecture, 792-0042, Japan. EZF03146@nifty.com.

Cardiovascular Intervention and Therapeutics
|October 24, 2019
PubMed
Summary

This study reviewed 28 years of data on how doctors perform heart spasm tests using acetylcholine. By comparing different access points for catheters and pacemakers, researchers identified the radial artery and brachial vein approach as a safer, more comfortable option for both patients and medical staff.

Keywords:
AcetylcholineBrachial veinRadial arterySpasm provocation testcardiac diagnostic testingvascular access sitescoronary artery spasmclinical procedural safety

Frequently Asked Questions

More Related Videos

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.7K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

4.1K

Related Experiment Videos

Last Updated: Jan 5, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

16.6K
Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.7K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

4.1K

Area of Science:

  • Cardiovascular medicine and acetylcholine spasm provocation test protocols
  • Interventional cardiology and clinical procedural outcomes

Background:

Clinical guidelines for diagnosing coronary artery spasms often require the use of temporary pacemakers during provocative testing. Despite the widespread adoption of acetylcholine testing, the optimal vascular access sites for these procedures remain debated. Prior research has shown that various arterial and venous combinations are utilized in clinical practice. That uncertainty drove this investigation into the long-term trends of procedural site selection. No prior work had resolved which specific combination offers the best balance of patient comfort and safety. This gap motivated a comprehensive review of historical testing data. Understanding these procedural shifts is vital for improving modern cardiac diagnostic standards. The current study addresses this need by evaluating nearly three decades of clinical experience.

Purpose Of The Study:

The study aimed to analyze the procedural changes and outcomes of acetylcholine spasm provocation tests over a 28-year period. Researchers sought to evaluate the safety and efficacy of different vascular access combinations for these tests. The motivation stemmed from the need to improve patient comfort and operator convenience during cardiac diagnostic procedures. By reviewing historical data, the team intended to identify the most effective approach for future clinical practice. The investigation focused on comparing five distinct arterial and venous entry site combinations. The authors addressed the necessity of temporary pacemaker insertion as a key component of the testing protocol. They also examined the incidence of complications associated with various access sites. This work provides a foundation for refining standard guidelines to enhance the overall quality of cardiac provocation testing.

Main Methods:

The investigators conducted a retrospective analysis of 1829 cardiac provocation tests performed over a 28-year period. They categorized patients based on the specific combination of arterial and venous access sites utilized. The team tracked the success rates for both arterial catheterization and temporary pacemaker placement. They also monitored the occurrence of procedure-related adverse events, including pulmonary embolism and arterio-venous fistula. The review approach involved comparing five distinct vascular access combinations across the entire patient cohort. Data were synthesized to evaluate the clinical performance and safety profiles of each method. This systematic examination allowed for the identification of trends in procedural site selection. The study design focused on optimizing the comfort and safety of the diagnostic process.

Main Results:

The radial artery and brachial vein approach emerged as the most favorable method for future clinical testing. This combination resulted in zero cases of pulmonary embolism or arterio-venous fistula. In contrast, other approaches showed varying rates of these specific complications during the study period. The researchers successfully performed acetylcholine testing via the femoral and brachial arteries in all patients. The radial artery approach achieved a high success rate of 97.1% across the cohort. Temporary pacemaker insertion was successful in 100% of cases using the femoral vein. The brachial vein approach for pacemaker insertion demonstrated a success rate of 94.8%. Despite these differences, the authors noted no significant variation in major procedure-related complications among the various tested methods.

Conclusions:

The researchers suggest that the radial artery and brachial vein approach provides a superior balance of comfort and safety. This specific combination demonstrated a favorable profile regarding procedure-related complications compared to other methods. The authors observed no instances of pulmonary embolism or arterio-venous fistula with this preferred technique. They propose that this approach should be prioritized for future diagnostic testing protocols. Their findings indicate that this method benefits both the patient and the operating medical team. The study highlights the importance of considering disinfection practices and overall procedural performance. These results offer a clear recommendation for refining standard clinical workflows. Future testing should reflect these insights to optimize patient outcomes and procedural efficiency.

The researchers propose that the radial artery and brachial vein approach is the most comfortable method. This technique resulted in zero cases of pulmonary embolism or arterio-venous fistula, unlike the femoral or brachial combinations which saw these specific complications.

The study utilized various vascular access combinations, including the femoral artery and vein, brachial artery and femoral vein, brachial artery and vein, radial artery and brachial vein, and radial artery and femoral vein. These sites were chosen to facilitate catheterization and temporary pacemaker insertion.

A temporary pacemaker is necessary for safety during acetylcholine provocation to manage potential bradycardia or conduction disturbances. The researchers found that the femoral vein approach achieved a 100% success rate for insertion, while the brachial vein approach succeeded in 94.8% of cases.

The authors analyzed 1829 cases over 28 years. This retrospective data allowed them to compare the success rates of different arterial and venous access points, such as the 97.1% success rate for the radial artery approach.

The researchers measured the success rates of vascular access and the frequency of complications like pulmonary embolism and arterio-venous fistula. They compared these metrics across five different combinations of arterial and venous entry points used throughout the study period.

The authors recommend the radial artery and brachial vein approach for future testing. They claim this method improves comfort for both patients and operators while maintaining a low risk of serious complications compared to traditional femoral or brachial techniques.